Response_Letter_HTH-2023-31534.pdf
Response_Package_HTH-2023-31534.pdf
FOI Request - HTH-2023-31534 Any directives related to criteria needed under BC's Biosimilars Initiative to approve Special Authority requests allowing patients with Crohn's disease or ulcerative colitis to remain on an originator biologic. In addition, we would like to request access to any table showing the number of Special Authority requests that have been made and the number approved or declined and any table showing the number of patients who experienced adverse events as a result of the biosimilar switch (Date Range for Record Search: From 4/1/2019 To 6/12/2023) FOI Request FOI Request 2023-09-25 Health 9 2023 Response_Letter_HTH-2023-31534.pdf Response_Package_HTH-2023-31534.pdf Business $0.00